Already a member? Click here to login.
Already a member? Click here to login.
ADEA has been advised by the Therapeutic Goods Administration (TGA) of the following:
Australasian Medical and Scientific Ltd (AMSL), in consultation with the TGA, has initiated a recall for product correction for Contact Detach infusion sets manufactured before May 2014 (see below for a list of affected lot numbers).
Please note that these products are not being removed from the market. Consumers will have the option of having the affected devices replaced free of charge, or continue using them in accordance with some additional instructions.
Contact Detach infusion sets are used in conjunction with a pump to deliver a continuous dose of insulin to help people with diabetes maintain normal blood glucose levels.
There has been a slight increase in reports of cases where the needles of these infusion sets have broken during use.
A list of affected lot numbers and other information is on the TGA website at: http://www.tga.gov.au/alert/contact-detach-infusion-sets
ADEA has been advised by the Therapeutic Goods Administration (TGA) of the following:
Australasian Medical and Scientific Ltd (AMSL), in consultation with the TGA, has initiated a recall for product correction for Contact Detach infusion sets manufactured before May 2014 (see below for a list of affected lot numbers).
Please note that these products are not being removed from the market. Consumers will have the option of having the affected devices replaced free of charge, or continue using them in accordance with some additional instructions.
Contact Detach infusion sets are used in conjunction with a pump to deliver a continuous dose of insulin to help people with diabetes maintain normal blood glucose levels.
There has been a slight increase in reports of cases where the needles of these infusion sets have broken during use.
A list of affected lot numbers and other information is on the TGA website at: http://www.tga.gov.au/alert/contact-detach-infusion-sets
